FDA Inspection 1079858 — Emcure Pharmaceuticals Limited

Emcure Pharmaceuticals Limited — FEI 3005151215

The FDA completed an inspection of Emcure Pharmaceuticals Limited on Feb 20, 2019 in Pune. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Feb 20, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pune (India)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
145121 CFR 211.113(b)Procedures for sterile drug products
193321 CFR 211.167(a)Sterility/pyrogens - test methods written, followed
202721 CFR 211.192Investigations of discrepancies, failures
240121 CFR 211.194(a)(4)Complete Test Data

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.